JNNP

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Journal of Neurology, Neurosurgery, and Psychiatry 2005;76:1045; doi:10.1136/jnnp.2005.063297
Copyright © 2005 by the BMJ Publishing Group Ltd.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sinzinger, H
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sinzinger, H
Related Collections
Right arrow Other Cardiovascular Medicine
Right arrow Stroke

EDITORIAL COMMENTARY

Risk factor profile

Does the risk factor profile have predictive value for the site of atherosclerosis?

H Sinzinger

Correspondence to:
Correspondence to:
Professor H Sinzinger
Institute for Diagnosis and Treatment of Atherosclerosis and Lipid Disorders (ATHOS), Nadlergasse 1, A-1090 Vienna, Austria; helmut.sinzinger@meduniwien.ac.at


Inflammatory markers are significantly higher in patients with carotid atherosclerosis than in those with middle cerebral artery (MCA) infarcts

Keywords: atherosclerosis; inflammation; risk factors

The first 150 words of the full text of this article appear below.

Atherosclerosis is increasingly linked with inflammation, a claim already made by Rudolf Virchow in 1856. Vascular biology has demonstrated that inflammation also plays a key role in stroke development. The best examined inflammatory marker is C-reactive protein (CRP). High sensitivity (hs)-CRP predicts the risk not reflected by traditional risk factors1 for stroke and coronary heart disease (CHD). Interleukin-6 is an even better predictor than CRP and correlates with stroke severity, infarct volume, and long term outcome and is an independent predictor of stroke2; hs-CRP is a more valuable predictor than low density lipoprotein cholesterol (LDL). As hs-CRP and LDL are additive predictors, they identify different risk factors.

The CRP gene markedly accelerates atherosclerosis, indicating an active role. CRP is locally generated within the arterial wall. Intraplaque inflammation may attenuate invasion of endothelial progenitor cells and has been postulated to play a crucial role in thinning of . . . [Full text of this article]







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2005 by the BMJ Publishing Group Ltd.